Literature DB >> 23589617

Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells.

Yi Ting Koh1, John C Scatizzi, Jennifer D Gahan, Brian R Lawson, Roberto Baccala, K Michael Pollard, Bruce A Beutler, Argyrios N Theofilopoulos, Dwight H Kono.   

Abstract

Nucleic acid (NA)-sensing TLRs (NA-TLRs) promote the induction of anti-nuclear Abs in systemic lupus erythematosus. However, the extent to which other nonnuclear pathogenic autoantibody specificities that occur in lupus and independently in other autoimmune diseases depend on NA-TLRs, and which immune cells require NA-TLRs in systemic autoimmunity, remains to be determined. Using Unc93b1(3d) lupus-prone mice that lack NA-TLR signaling, we found that all pathogenic nonnuclear autoantibody specificities examined, even anti-RBC, required NA-TLRs. Furthermore, we document that NA-TLRs in B cells were required for the development of antichromatin and rheumatoid factor. These findings support a unifying NA-TLR-mediated mechanism of autoantibody production that has both pathophysiological and therapeutic implications for systemic lupus erythematosus and several other humoral-mediated autoimmune diseases. In particular, our findings suggest that targeting of NA-TLR signaling in B cells alone would be sufficient to specifically block production of a broad diversity of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589617      PMCID: PMC3729324          DOI: 10.4049/jimmunol.1202986

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies.

Authors:  M Sorice; A Circella; R Misasi; V Pittoni; T Garofalo; A Cirelli; A Pavan; G M Pontieri; G Valesini
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Overlap of the anti-cardiolipin and anti-nucleosome responses of the (NZW X BXSB)F1 mouse strain: a new pattern of cross-reactivity for lupus-related autoantibodies.

Authors:  D Gilbert; B Lopez; J Parain; S Koutouzov; F Tron
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

3.  Cutting edge: TLR13 is a receptor for bacterial RNA.

Authors:  Asa Hidmark; Antonia von Saint Paul; Alexander H Dalpke
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

4.  TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation.

Authors:  Kevin M Nickerson; Sean R Christensen; Jaime L Cullen; Wenzhao Meng; Eline T Luning Prak; Mark J Shlomchik
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

5.  Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner.

Authors:  B E Price; J Rauch; M A Shia; M T Walsh; W Lieberthal; H M Gilligan; T O'Laughlin; J S Koh; J S Levine
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

Review 6.  Lessons from BXSB and related mouse models.

Authors:  S Izui; N Ibnou-Zekri; L Fossati-Jimack; M Iwamoto
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

7.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

8.  Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Amanda L Blasius; Ivo Rimann; Keiko Ozato; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii.

Authors:  A Alicia Koblansky; Dragana Jankovic; Hyunju Oh; Sara Hieny; Waradon Sungnak; Ramkumar Mathur; Matthew S Hayden; Shizuo Akira; Alan Sher; Sankar Ghosh
Journal:  Immunity       Date:  2012-12-13       Impact factor: 31.745

Review 10.  TLR8: the forgotten relative revindicated.

Authors:  Jorge L Cervantes; Bennett Weinerman; Chaitali Basole; Juan C Salazar
Journal:  Cell Mol Immunol       Date:  2012-10-22       Impact factor: 11.530

View more
  27 in total

Review 1.  The multiple pathways to autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Roberto Baccala
Journal:  Nat Immunol       Date:  2017-06-20       Impact factor: 25.606

2.  Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus.

Authors:  William E O'Gorman; Elena W Y Hsieh; Erica S Savig; Pier Federico Gherardini; Joseph D Hernandez; Leo Hansmann; Imelda M Balboni; Paul J Utz; Sean C Bendall; Wendy J Fantl; David B Lewis; Garry P Nolan; Mark M Davis
Journal:  J Allergy Clin Immunol       Date:  2015-05-30       Impact factor: 10.793

3.  B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers.

Authors:  Chetna Soni; Eric B Wong; Phillip P Domeier; Tahsin N Khan; Takashi Satoh; Shizuo Akira; Ziaur S M Rahman
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

Review 4.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

Review 5.  Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.

Authors:  Leo A B Joosten; Shahla Abdollahi-Roodsaz; Charles A Dinarello; Luke O'Neill; Mihai G Netea
Journal:  Nat Rev Rheumatol       Date:  2016-05-12       Impact factor: 20.543

6.  Neurotoxic or Neuroprotective? Current Controversies in SCI-Induced Autoimmunity.

Authors:  Jonah W Saltzman; Ricardo Battaglino; Helen Stott; Leslie R Morse
Journal:  Curr Phys Med Rehabil Rep       Date:  2013-09

Review 7.  Contributions of B cells to lupus pathogenesis.

Authors:  Allison Sang; Ying-Yi Zheng; Laurence Morel
Journal:  Mol Immunol       Date:  2013-12-12       Impact factor: 4.407

8.  Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.

Authors:  K Michael Pollard; Gabriela M Escalante; Hua Huang; Katarina M Haraldsson; Per Hultman; Joseph M Christy; Rahul D Pawar; Jessica M Mayeux; Rosana Gonzalez-Quintial; Roberto Baccala; Bruce Beutler; Argyrios N Theofilopoulos; Dwight H Kono
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

Review 9.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

10.  Generation of functional murine CD11c+ age-associated B cells in the absence of B cell T-bet expression.

Authors:  Samuel W Du; Tanvi Arkatkar; Holly M Jacobs; David J Rawlings; Shaun W Jackson
Journal:  Eur J Immunol       Date:  2018-11-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.